NeuroMetrix, Inc., a Massachusetts-based medical device company, has filed a 510(k) form with the US Food and Drug Administration for the SENSUSTM, a pain therapy device for people who suffer diabetic neuropathy. A 510(k) is a “premarket notification” of a company’s intent to market a medical product. The FDA then tests the product and provides feedback to the manufacturer
The FDA has approved the start of outpatient trials of a smart phone-based monitoring device that functions as an artificial pancreas.
As we approach the summer season, our thoughts turn to barbecues, picnics, amusement parks, and road trips to the beach.
There are lots of articles about diabetes, as well as all kinds of information about anemia.
British researchers say that metformin, the drug most often used to treat prediabetes and type 2 diabetes, could provide potential protection against endometrial cancer in women.
Up to seven years before she becomes pregnant, a woman’s risk of developing diabetes during pregnancy can be identified based on routinely assessed measures of blood sugar and body weight, according to a Kaiser Permanente study published in the online issue of the American Journal of Obstetrics and Gynecology.